Plus Therapeutics wins Elevance Health coverage deal
Seeking Alpha ·
Plus Therapeutics ( PSTV ) shares rose in early premarket trading after its subsidiary CNSide Diagnostics announced an agreement with Elevance Health ( ELV ) to expand coverage for a cancer screening test. The national agreement allows members of Elevance ( ELV ) to get
DYAX Investor Sentiment
Bullish (Long) 52% · Bearish (Short) 48%
283 participants
Related News
- WisdomTree U.S. Total Dividend Fund declares monthly distribution of $0.2100
- WisdomTree U.S. SmallCap Dividend Fund declares monthly distribution of $0.1450
- Supreme Court hands Bayer major victory in Roundup cancer litigation
- WisdomTree U.S. Quality Dividend Growth Fund declares monthly distribution of $0.1600
- WisdomTree U.S. MidCap Dividend Fund declares monthly distribution of $0.1550
- WisdomTree U.S. LargeCap Dividend Fund declares monthly distribution of $0.2050